Novavax Sell, Zscaler & Phibro Animal Health Buy
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Novavaxs growth stock soars, but gravity sets in; consider selling. Zscaler and Phibro Animal Health poised for upside. Novavaxs revenue growth lags peers, analysts predict sales drop, and cash flow margin shrinks. Post-pandemic market shift favors zero-trust security and animal health sectors. Zscalers billings grow, revenue expected to rise, and strong cash flow margin. Phibro Animal Health posts growth, rising profits, and earnings. Long-term picks beat fads; review full reports before market moves.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/4edcb92ca73d77fb